Case Studies

An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...

Recent Blog Posts

Tony Coelho Discusses Patient Care with Former HHS Secretary
February 3, 2012 |

On Tuesday night, PIPC Chairman Tony Coelho joined former HHS Secretary Tommy Thompson at the University of Charleston in West Virginia for a speaker series titled "Who Decides Patient Treatments" to discuss the future of health care in the United States.

 | Read More
PCORI Releases their Draft Priorities
January 30, 2012 |

PCORI released a draft of their National Priorities for Research and Research Agenda for public comment. The PCORI Board, which is responsible for funding research, is asking for a 55 day public comment period to discuss and solicit feedback from patients, caregivers, professionals, and the general public on the research priorities.

In the draft, PCORI prioritized five broad research areas:

 | Read More
Differentiating Patients, Consumers, and Patient Advocacy Organizations
October 18, 2011 |

When conducting Comparative Effectiveness Research it is crucial to understand the differences between the players involved in the process. In his remarks at the  2nd Annual Forum on Achieving Patient centeredness , Marc Boutin, executive vice president and COO at the National Health Council, discussed the important differences between the three major players in the process: the patient, the consumer, and the patient advocacy organization. He stated that many times when the patient is discussed they are not defined.

 | Read More

For Reporters

For journalists and other media professionals

More Information

Stay Connected

Groopman

Researcher knows common flaws in CER studies, dangers of result's misuse

Submitted by Tony Coelho on Mon, 03/08/2010 - 23:13 | Posted in:

A recent article by Jerome Groopman, M.D, provides some valuable, first-hand insight as to what can go wrong when policy makers “give teeth” to comparative effectiveness research (CER) studies by translating results into “best practices.” Groopman’s understanding of the limitations of CER and the complexities of delivery high quality care to each patient, lead him to caution against blunt application of CER in ways that do not give physicians the ability to deviat

Syndicate content